Trade Spotlight | How to trade in Zydus Lifesciences, Hind Copper and Siemens todayMoneycontrol • 4 days ago
Siemens ended at new closing high of Rs 5,768, and formed long bullish candlestick pattern on the daily timeframe, while the trading volumes in last three sessions remained healthy.
Share to Feed
Incred Equities estimates Mirabegron to be a $75-80 million opportunity for Zydus Lifesciences, as the company also enjoys a 180-day exclusivity period
After witnessing consistent double-digit growth in branded formulations business in recent years, growth in the domestic formulation segment has moderated to high single digits
USFDA inspected Zydus Lifesciences' Onco injectable manufacturing plant in Ahmedabad from March 18 to 27
Earlier on 26 March, Zydus Life's shares surged after the company received tentative approval from the US Food and Drug Administration (FDA) for its Letermovir tablets.
Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated March 20, 2024.
The drug will target specific genetic mutations prevalent in certain types of cancers, paving the way for more tailored and effective treatment approach.
Linde India has seen a nice breakout of downward sloping resistance trendline adjoining highs of October 12, 2023 and February 19, 2024. The stock formed long bullish candlestick pattern on the daily charts with above average volumes.
KR Choksey is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 1006 in its research report dated March 06, 2024.
Zydus Lifesciences formed strong bullish candlestick pattern on the daily charts, with robust volumes, while on the monthly basis, it has continued run up for fourth consecutive month.